Hyvv is a clinical trial intelligence platform for sponsors.
In rare disease, your site list decides whether the trial recruits. Patients sit in a small number of centres, the same investigators appear on every competing study in the indication, and a country chosen on familiarity rather than evidence can cost a year of enrolment.
Hyvv gives sponsors an independent read on feasibility before that list is locked. Every country and site is scored against patient epidemiology, competing trial density, treatment landscape, site capability, investigator workload and regulatory environment, and returned as a protocol-specific report in days.
Independent feasibility intelligence, delivered before the decisions become expensive.